Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)
February 24 2022 - 4:06PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
25
NOTIFICATION
OF REMOVAL FROM LISTING AND/OR
REGISTRATION
UNDER SECTION 12(b) OF THE
SECURITIES
EXCHANGE ACT OF 1934.
Commission
File Number 001-38396
BIOFRONTERA
AG, NASDAQ Capital Market
(Exact
name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
Hemmelrather
Weg 201
D-51377
Leverkusen, Germany
Telephone:
+49 (0)214 873 3200
(Address,
including zip code, and telephone number, including area code, of Issuer’s principal executive offices)
American
Depositary Shares, each representing two ordinary shares, nominal value €1.00 per share
Ordinary
shares, nominal value €1.00 per share*
(Description
of class of securities)
*
Not for trading, but only in connection with the registration of the American Depositary Shares.
Please
place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
☐
17 CFR 240.12d2-2(a)(1)
☐
17 CFR 240.12d2-2(a)(2)
☐
17 CFR 240.12d2-2(a)(3)
☐
17 CFR 240.12d2-2(a)(4)
☐
Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw
registration on the Exchange.(1)
☒
Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of the Exchange and the requirements of 17 CFR 240.12d2-2(c)
governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
Pursuant
to the requirements of the Securities Exchange Act of 1934, BIOFRONTERA AG certifies that it has reasonable grounds to believe that it
meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly
authorized person.
February
24, 2022 |
|
By
|
/s/
Ludwig Lutter |
|
Chief
Financial Officer |
Date |
|
|
Name |
|
Title |
(1)
Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.
SEC
1654 (03-06) |
Persons
who respond to the collection of information contained in this form are not required to respond unless the form displays a currently
valid OMB control number. |
Biofrontera (NASDAQ:BFRA)
Historical Stock Chart
From Jul 2024 to Aug 2024
Biofrontera (NASDAQ:BFRA)
Historical Stock Chart
From Aug 2023 to Aug 2024